P422: OMIPALISIB, A DUAL PI3K/MTOR INHIBITOR, TARGETS MITOCHONDRIA AND IMPAIRS OXIDATIVE PHOSPHORYLATION IN ACUTE MYELOID LEUKEMIA

• C.-Y. Tseng,
• C.-Y. Kuo,
• Y.-H. Fu,
• H.-A. Hou,
• H.-F. Tien,
• L.-I. Lin

Affiliations

C.-Y. Tseng

1 Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan

C.-Y. Kuo

1 Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan

Y.-H. Fu

1 Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan

H.-A. Hou

3 Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

H.-F. Tien

3 Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

L.-I. Lin

1 Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan